XML 24 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity
 6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 8: SHAREHOLDERS’ EQUITY

 

  a. In April 2022, a total of 1,000 options were exercised for the amount of $2.

 

  b. On May 2, 2022, the Company entered into a definitive agreement with several investors for the sale  of 450,000 units, each consisting of one ordinary share and one half warrant to purchase an ordinary share, at a unit purchase price of $2.2. The warrants have an exercise price of $2.2 per ordinary share and are immediately exercisable into ordinary shares over a five-year term. The sale was made in a registered direct offering with a total gross amount of $990 or $911 net of incremental and direct issuance expenses.  

 

  c. In June 2021, a total of 25,399 options were exercised for the amount of $59.

 

  d. On March 31, 2021, the Company issued 7,188 ordinary shares (equivalent to $27) to an officer of the Company as a bonus, which was approved by the Board of Directors and shareholders.

 

  e. On January 4, 2021, the Company entered into a definitive agreement with several institutional investors for the sale of 800,000 units, each consisting of one ordinary share and 0.9 of a warrant to purchase an ordinary share at a combined purchase price of $2.5.  The warrants have an exercise price of $2.75 per share and are immediately exercisable into ordinary shares over a five-year term. The sale was made in a registered direct offering with a total gross amount of $2,000 or $1,841 net of incremental and direct issuance expenses.